Extended blood thinner use for left ventricle blood clots
Part of Heart & circulation clinical trials.
This trial studies whether taking blood thinners for longer helps people whose heart’s main pumping chamber (the left ventricle) has a blood clot. The goal is to see if it prevents further problems like strokes or clot growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been told you have a blood clot in the left ventricle of your heart, confirmed by an ultrasound.
- You are 18 years or older and agree to take part in the study.
- You do not have a history of not following treatment plans or refusing study participation.
- You are not allergic to blood thinners and do not have a condition that makes them unsafe.
- You have not had or are not planning certain heart surgeries, like removing the clot or getting a transplant.
- You do not have other reasons for long-term blood thinning, like a mechanical heart valve or irregular heartbeat.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This trial compares the blood thinner apixaban to warfarin for treating blood clots in the main pumping chamber of the heart (left ventricle). The goal is to see which medicine is better at preventing strokes and other complications.
This trial tests if patients with a blood clot in the left ventricle can safely stop blood thinner (Apixaban) after at least 3 months, instead of taking it longer. It may help people with no additional risks avoid extra medication.
This trial tests how to use a blood thinner in people after a recent heart attack who have a clot in the left heart chamber confirmed by heart MRI. It may help lower the risk of the clot causing serious complications, but it also requires careful bleeding-safety screening.
This trial tests how well blood thinners (anticoagulants) work to dissolve clots in the heart of people with atrial fibrillation (an irregular heartbeat). It aims to find the best treatment for these clots before more serious complications occur.
This study looks at people age 18+ who were found to have a blood clot in the left side of the heart (left ventricular thrombus) on scans between 2013 and 2020. It will compare how different blood-thinner medicines were used and what outcomes occurred.
Hear when a new Embolism and Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.